Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer

Chandra P. Belani, Wei Wang, David H. Johnson, Henry Wagner, Joan Schiller, Michael Veeder, Minesh Mehta

Int Med - Chairman's Office
Internal Medicine

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer

Fingerprint

Medicine & Life Sciences